NASDAQ: LSBLakeshore Biopharma Co Ltd Earnings Dates, Reports, Calls
Lakeshore Biopharma Co earnings were -$100.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest LSB earnings report on Mar 31, 2025 announced Q1 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, LSB reported annual earnings of -$100.0M, with -76.9% growth.
LSB earnings history
Current Revenue
$615.0M
Current Earnings
-$100.0M
Current Profit Margin
-16.3%
LSB Return on Equity
Current Company
-18.4%
Current Industry
-60.2%
Current Market
31.3%
LSB's Return on Equity (-18.4%)... subscribe to Premium to read more.
High Return on Equity Performance
LSB undefined
Current Company
-6.9%
Current Industry
-2.5%
LSB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when LSB announces earnings.
LSB undefined
Current Company
-15.69%
Current Industry
5.8%
LSB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance
LSB vs Biotech Stocks
Lakeshore Biopharma Co Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.